Reclassifying DCIS: A Groundbreaking Shift in Breast Cancer Diagnosis After Over a Decade of Advocacy
For over a decade, GreenMedInfo has championed the classification of ductal carcinoma in situ (DCIS) as something other than cancer, standing firm against the tide of overdiagnosis and overtreatment.
Quick Summary:
GreenMedInfo’s Advocacy: Since 2008, GreenMedInfo has worked to redefine DCIS based on evidence showing its non-invasive nature.
COMET Study Validation: Recent findings affirm that active monitoring is often safer and equally effective compared to aggressive treatments.
Future Implications: A shift in the DCIS classification could drasticall…
Keep reading with a 7-day free trial
Subscribe to Sayer Ji's Substack to keep reading this post and get 7 days of free access to the full post archives.